Clinical trials: Respiratory Viral Infections
Covid19, Right Ventricular Dysfunction
Right Ventricular Dysfunction in Ventilated Patients With COVID-19
Using echocardiography to investigate the incidence of RV dysfunction in ventilated patients with COVID-19.
- Conditions
- Covid19, Right Ventricular Dysfunction, ARDS
- Trial name
- COVID-RV (NCT04764032)
- Testing
- Echocardiography
- Where
- 11 sites in United Kingdom
- Volunteers
- 150 people
- Sponsor
- University of Glasgow
COVID-19 Pneumonia, COVID-19 Respiratory Infection
A Proof-of-Concept Study Evaluating EOM613 in COVID-19 Infected Patients With Severe Symptoms
The purpose of this study is to evaluate the safety, tolerability and preliminary efficacy of EOM613, a peptide nucleic acid with novel immune-modulating properties, in treating patients with severe COVID-19 infections.
- Conditions
- COVID-19 Pneumonia, COVID-19 Respiratory Infection, COVID-19 Acute Respiratory Distress Syndrome
- Trial name
- NCT05212532
- Testing
- EOM613
- Where
- 4 sites in Brazil
- Volunteers
- 40 people
- Sponsor
- EOM Pharmaceuticals
Acute Respiratory Viral Infection
A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness
The purpose of the study is to describe the rate of occurrence of clinical diagnosis of acute respiratory infection (an infection that affects normal breathing) and different types of respiratory pathogens (harmful organisms) of…
- Trial name
- BREEZE (NCT05661604)
- Testing
- No Intervention
- Where
- 4 sites in United States, Canada
- Volunteers
- 140 people
- Sponsor
- Janssen Research & Development, LLC
COVID-19, Convalescence
Moxibustion Plus Cupping in Convalescent Patients With COVID-19
This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.
- Trial name
- NCT04374084
- Testing
- Moxibustion plus Cupping
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Influenza
Asymptomatic Flu Project
Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very important because of the risk of…
- Trial name
- AFP (NCT02868658)
- Testing
- Blood sampling, Nasal swab
- Where
- France
- Volunteers
- 289 people, healthy volunteers welcome
- Sponsor
- Hospices Civils de Lyon
Fecal Microbiota Transplantation, COVID-19 Infection
A Controlled Study on Regulation of Systemic Inflammation by Fecal Bacteria Transplantation in Patients With COVID-19.
A total of 30 hospitalized patients with COVID-19 over 60 years old were enrolled in this study and were divided into the experimental group (n=15) and the control group (n=15) at a ratio of 1:1.
- Trial name
- NCT05873348
- Testing
- Fecal microbiota transplantation
- Where
- China
- Volunteers
- 30 people
- Sponsor
- Shanghai 10th People's Hospital
COVID-19 Pandemic
Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine
This is a study trial to assess the effectiveness of the immune response stimulated by the genetically engineered Bacillus subtilis spore extract which contain Spike protein of the SARS-COV2 on the spore coat.
- Trial name
- NCT05158855
- Testing
- Bacillus subtilis spore extract
- Where
- Macau
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- DreamTec Research Limited
Acute Viral Bronchitis, Hypoxemic Respiratory Failure
NHF vs. COT in Hypoxemic Pandemic Viral Illness
The study compares oxygen and NHF in patients with acute viral illness. The duration will be 72h. After them physiological parameters and the outcome will be evaluated.
- Conditions
- Acute Viral Bronchitis, Hypoxemic Respiratory Failure, Hypercapnic Respiratory Failure
- Trial name
- HIVI (NCT04750408)
- Testing
- Standard oxygen, Nasal high-flow
- Where
- Germany
- Volunteers
- 52 people
- Sponsor
- Jens Bräunlich
Rheumatoid Arthritis, Influenza
2-week dc of MTX and Influenza Vaccination in RA
To investigate whether a transient discontinuation of methotrexate MTX for 2 weeks improves the vaccination response to a seasonal influenza.
- Conditions
- Rheumatoid Arthritis, Influenza, Methotrexate
- Trial name
- 2 wk MTX (NCT02897011)
- Testing
- Methotrexate
- Where
- 3 sites in South Korea
- Volunteers
- 318 people
- Sponsor
- Seoul National University Hospital
COVID-19
A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
The aim of this phase 2 study is to evaluate the safety and efficacy of single dose IV infusion of BRII-196 and BRII-198 given as combination therapy in patients with severe COVID-19, and mild to moderate COVID-19 and…
- Trial name
- NCT04787211
- Testing
- BRII-196 and BRII-198
- Where
- 6 sites in China
- Volunteers
- 48 people
- Sponsor
- Brii Biosciences Limited
COVID-19
Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults
Phase I/II study to determine safety, tolerance and immunogenicity of EuCorVac-19, a recombinant protein vaccine, for the prevention of COVID-19 in healthy adults
- Trial name
- NCT04783311
- Testing
- EuCorVac-19, Normal Saline
- Where
- South Korea
- Volunteers
- 279 people, healthy volunteers welcome
- Sponsor
- EuBiologics Co.,Ltd
Influenza
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers
The purpose of this study is to assess the humoral immune response and safety of the parenteral formulation of the 2010/2011-season virosomal subunit influenza vaccine Inflexal V using two different HA antigen suppliers (AdImmune…
- Trial name
- NCT01229371
- Testing
- Inflexal V influenza vaccine (CSL HA Antigen) 2010, Inflexal V influenza vaccine (AdImmune HA antigen) 2010/2011
- Where
- 2 sites in Switzerland
- Volunteers
- 440 people, healthy volunteers welcome
- Sponsor
- Crucell Holland BV
Rehabilitation, Post-Acute COVID-19 Syndrome
RCT Long COVID-19 Rehabilitation
The Coronavirus 2019 (COVID-19) pandemic has resulted in at least four million infections in Norway. The vast majority of cases are diagnosed and followed up in the community, but some with extensive symptoms and large degree of…
- Conditions
- Rehabilitation, Post-Acute COVID-19 Syndrome, Post-Infectious Disorders
- Trial name
- NCT06085911
- Testing
- One day course, Individual follow-ups
- Where
- Norway
- Volunteers
- 60 people
- Sponsor
- University Hospital of North Norway
Covid19
Intravenous Infusion of CAP-1002 in Patients With COVID-19
This is a randomized, double-blind, placebo-controlled, Pilot, Phase 2 Exploratory study that will enroll subjects with a clinical diagnosis of COVID-19 confirmed by laboratory testing and who are in severe or critical condition…
- Trial name
- INSPIRE (NCT04623671)
- Testing
- CAP-1002
- Where
- 4 sites in United States
- Volunteers
- 55 people
- Sponsor
- Capricor Inc.
Covid19
ACTIV-3: Therapeutics for Inpatients With COVID-19
This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection.
- Trial name
- TICO (NCT04501978)
- Testing
- LY3819253, Remdesivir, VIR-7831
- Where
- 135 sites in United States, Denmark and 8 more
- Volunteers
- 2,753 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Upper Respiratory Tract Infections
The Association of Hand Hygiene Practice on Primary Schoolgirls Absence Due to URIs in Riyadh City, 2017-2018.
Research Problem: Upper respiratory infections (URIs) are a common reason for absence from schools as it is estimated that children get six to eight episodes every year.
- Trial name
- NCT03535064
- Testing
- Hand Hygiene Workshop
- Where
- Saudi Arabia
- Volunteers
- 496 people
- Sponsor
- Abrar Alzaher
SARS-CoV-2 (COVID-19)
Rapid Screening Circuit of COVID 19 in Schools, Pilot Study
The outbreak of coronavirus disease 2019 (COVID-19), caused by acute respiratory syndrome severe coronavirus 2 (SARS-CoV-2), emerged in Wuhan in December 2019 and has spread which poses a serious threat to public health.
- Trial name
- NCT04878809
- Testing
- Escola L'Horitzó, Escola John Talabot
- Where
- 2 sites in Spain
- Volunteers
- 153 people, healthy volunteers welcome
- Sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
COVID-19
Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines
It is a prospective open-labeled study, We intended to recruit the participants who completed 2 doses of inactivated COVID-19 vaccine 4-8 months before, and volunteered to receive the third dose of vaccine (inactivated vaccine…
- Trial name
- NCT05095298
- Testing
- Vaccine, COVID19
- Where
- 2 sites in China
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- Huashan Hospital
COVID-19
A Study to Determine the Tolerability of Intranasal LMN-301
LMN-301 is to prevent infection by severe acute respiratory syndrome-corona virus (SARS-CoV-2) (the virus causing coronavirus disease of 2019 (COVID-19) in uninfected individuals.
- Trial name
- NCT06030414
- Testing
- LMN-301
- Where
- Australia
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- Lumen Bioscience, Inc.
COVID-19, Desaturation of Blood
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic.So far, no specific treatment has proven efficacy. Recent case series reported the use of Hyperbaric Oxygen Therapy (HBOT) on 5 severe COVID-19 patients…
- Trial name
- HBOTCOVID19 (NCT04358926)
- Testing
- Hyperbaric oxygen therapy
- Where
- Israel
- Volunteers
- 30 people
- Sponsor
- Assaf-Harofeh Medical Center